This book explores new ground in the field of cutting-edge cancer treatment modalities by presenting contemporary biotechnological developments as a component of cancer targeting techniques. It addresses the application of modern technologies in cancer detection, targeting, and the development of therapeutic strategies across fifteen comprehensive chapters. The book emphasizes the advantages of molecular techniques for cancer therapies, such as molecular diagnosis, cell and gene therapy, and immunotherapy, with a dedicated chapter on personalized cancer therapy to critically analyze the progression toward precision strategies.

The chapters cover topics such as molecular biomarkers, microRNAs, and the potential of nanomedicine in cancer treatment. The authors provide expert analysis on the latest research, offering insights into the outcomes of scientific and clinical trials. Readers will also discover discussions on drug resistance, novel molecular targets, and the integration of biotechnology in drug discovery and development. Particular attention is given to the role of epigenetics and RNA interference in cancer therapy, as well as the challenges and future prospects of personalized medicine.

This book is designed specifically for oncologists, cancer biologists, researchers, academicians, and students interested in understanding the most cutting-edge biotechnological aspects of cancer therapeutics. It offers a comprehensive overview of cancer prevention, therapeutics, and treatments through the perspectives of technology, medicine, and alternative therapies. Researchers in the field of biotechnology and cancer therapy will find this book invaluable for its detailed discussions and insights into the latest advancements. It serves as a crucial tool for those working in this area, providing a valuable resource for understanding the complexities of cancer therapies and fostering progress in the field.

Overviews the use of contemporary technologies in cancer detection, targeting, and designing therapeutic strategies Highlights the benefits of molecular approaches, personalized medicine, and nanotechnology for cancer therapies Covers the technology, medicine, and alternative therapies in cancer prevention and treatment

Autorentext

Dr. Manisha Nigam

Dr. Manisha Nigam, Assistant Professor and Head of the Biochemistry Department at Hemvati Nandan Bahuguna Garhwal University, Uttarakhand, India, brings over 20 years of research expertise and 11 years of teaching experience to the field. Her research primarily explores the role of oxidative stress in diseases like cancer and investigates natural plant-based compounds as potential therapeutic agents. Dr. Nigam completed her Master’s in Biochemistry from the esteemed Lucknow University and earned her Ph.D. at the Central Drug Research Institute, with her doctoral degree conferred by the University of Allahabad. She is a prolific author, having published numerous peer-reviewed articles and presented at both national and international forums. Dr. Nigam also contributes as a reviewer and editorial board member for various respected journals. Beyond her research and teaching, she plays a vital role in university administration, serving as the Assistant Director of the Research & Development Cell and Assistant Proctor.

Dr. Abhay Prakash Mishra

Dr. Abhay Prakash Mishra is a Senior Researcher at the Cosmetics and Natural Product Research Center (CosNat), Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand. He previously held a postdoctoral fellowship at the Department of Pharmacology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa, and also at the Center for Drug Discovery Research and Development, Ain Shams University, Egypt. His current research focuses on formulating phytopharmaceuticals for anti-inflammatory, antimicrobial, and antioxidative activities as potential therapeutic agents. Dr. Mishra obtained his Master’s in Pharmaceutical Chemistry from Hemvati Nandan Bahuguna Garhwal University, Uttarakhand, India, and earned his Ph.D. from Uttarakhand Technical University, Uttarakhand, India. He is a productive researcher, with numerous peer-reviewed articles and keynote addresses at both national and international forums to his credit. Dr. Mishra also serves as a reviewer and editorial board member for several respected journals.

Klappentext

.- Chapter 1: Biotechnology in Medicine: Fundamentals .- Chapter 2: Molecular Diagnosis in Cancer .- Chapter 3: Cancer Immunotherapy .- Chapter 4: RNAi in Cancer Therapy - RNA Interference (RNAi): A Promising Frontier in Cancer Therapy - Mechanisms, Challenges, and Future Perspectives .- Chapter 5: Cell Therapy of Cancer .- Chapter 6: Personalized Cancer Therapy .- Chapter 7: Drug Resistance and Novel Targets for Cancer Therapy .- Chapter 8: Epigenetics: Applications in Cancer Therapeutics .- Chapter 9: Biomarkers of Cancer .- Chapter 10:Small molecules in targeted cancer therapy .- Chapter 11:Monoclonal Antibodies and Cancer .- Chapter 12:Role of MicroRNAs in Cancer .- Chapter 13:Gene therapy of cancer .- Chapter 14:Biotechnology in drug discovery and development for cancer.

Inhalt

.- Chapter 1: Biotechnology in Medicine: Fundamentals
.- Chapter 2: Molecular Diagnosis in Cancer
.- Chapter 3: Cancer Immunotherapy
.- Chapter 4: RNAi in Cancer Therapy - RNA Interference (RNAi): A Promising Frontier in Cancer Therapy - Mechanisms, Challenges, and Future Perspectives
.- Chapter 5: Cell Therapy of Cancer
.- Chapter 6: Personalized Cancer Therapy
.- Chapter 7: Drug Resistance and Novel Targets for Cancer Therapy
.- Chapter 8: Epigenetics: Applications in Cancer Therapeutics
.- Chapter 9: Biomarkers of Cancer
.- Chapter 10:Small molecules in targeted cancer therapy
.- Chapter 11:Monoclonal Antibodies and Cancer
.- Chapter 12:Role of MicroRNAs in Cancer
.- Chapter 13:Gene therapy of cancer
.- Chapter 14:Biotechnology in drug discovery and development for cancer.